RHF has long been hypothesized as one of the main mechanisms of renal disease progression, irrespective of the underlying causes of CKD and the measures alleviating RHF, such as restriction of dietary protein and salt intake and anti-hypertensive therapy, especially the renin-angiotensin-aldosterone system blockers, have been recommended to patients with CKD [18]. This evidence concerns the gene REN and kidney disorder.